Similar articles for PMID: 19317313

Year	Number of Results
2001	1
2002	1
2003	3
2004	4
2005	8
2006	18
2007	24
2008	47
2009	57
2010	12
2011	14
2012	11
2013	22
2014	18
2015	14
2016	12
2017	12
2018	8
2019	8
2020	7
2021	10
2022	7
2023	1
2024	0

1

[Statins: what is their place in the treatment of chronic kidney insufficiency?].

Ponte B, Bourquin V, Stoermann-Chopard C. Ponte B, et al. Rev Med Suisse. 2009 Feb 25;5(192):463-4, 466-8. Rev Med Suisse. 2009. PMID: 19317313 French.

2

Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.

Kanbay M, Turgut F, Covic A, Goldsmith D. Kanbay M, et al. J Nephrol. 2009 Sep-Oct;22(5):598-609. J Nephrol. 2009. PMID: 19809992 Review.

3

Is lipid management effective for all stages of CKD?

Ku E, Campese V. Ku E, et al. Blood Purif. 2013;35(1-3):26-30. doi: 10.1159/000345932. Epub 2013 Jan 22. Blood Purif. 2013. PMID: 23343543 Free article. Review.

4

Management of dyslipidemias in patients with diabetes and chronic kidney disease.

Molitch ME. Molitch ME. Clin J Am Soc Nephrol. 2006 Sep;1(5):1090-9. doi: 10.2215/CJN.00780306. Epub 2006 Jul 26. Clin J Am Soc Nephrol. 2006. PMID: 17699330 Review.

5

Managing dyslipidemia in chronic kidney disease.

Harper CR, Jacobson TA. Harper CR, et al. J Am Coll Cardiol. 2008 Jun 24;51(25):2375-84. doi: 10.1016/j.jacc.2008.03.025. J Am Coll Cardiol. 2008. PMID: 18565393 Free article. Review.

6

HMG CoA reductase inhibitors and renoprotection: the weight of the evidence.

Romayne Kurukulasuriya L, Athappan G, Saab G, Whaley Connell A, Sowers JR. Romayne Kurukulasuriya L, et al. Ther Adv Cardiovasc Dis. 2007 Oct;1(1):49-59. doi: 10.1177/1753944707082714. Ther Adv Cardiovasc Dis. 2007. PMID: 19124395 Free article. Review.

7

Lipid changes and statins in chronic renal insufficiency.

Ritz E, Wanner C. Ritz E, et al. J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S226-30. doi: 10.1681/ASN.2006080919. J Am Soc Nephrol. 2006. PMID: 17130266 Review.

8

[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].

Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F. Cases Amenós A, et al. Nefrologia. 2008;28 Suppl 3:39-48. Nefrologia. 2008. PMID: 19018737 Spanish.

9

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.

Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J. Chonchol M, et al. Am J Kidney Dis. 2007 Mar;49(3):373-82. doi: 10.1053/j.ajkd.2006.11.043. Am J Kidney Dis. 2007. PMID: 17336698 Clinical Trial.

10

The dyslipidemia of chronic renal disease: effects of statin therapy.

Ozsoy RC, van Leuven SI, Kastelein JJ, Arisz L, Koopman MG. Ozsoy RC, et al. Curr Opin Lipidol. 2006 Dec;17(6):659-66. doi: 10.1097/MOL.0b013e328010a87d. Curr Opin Lipidol. 2006. PMID: 17095911 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

293 results

Results by year